MDLN logo

MEDLINE INC-CL A

MDLNNASDAQ
πŸ† #412 by market capEarnings Nov 4US Equity
$32.37β–Ό $0.01 (βˆ’0.03%)
πŸŒ™ After hours$32.32β–Ό 0.15%Regular close Β· extended-hours price shown
πŸ””
Track MDLN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.0%
7dβ–Ό 7.2%
14dβ–Ό 11.5%
30dβ–Ό 7.4%
ytdβ–Ό 22.9%
1yβ€”
🏦Market Cap
$28.40B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
11.5%
Healthy
πŸ“ŠGross Margin
25.0%
Moderate
πŸ’΅FCF Margin
6.8%
Moderate
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$32.06 – $32.72
52-Week Range
$31.49 – $50.88
Volume (shares)
8,153,437
Avg Volume (shares)
β€”
Shares Outstanding
877.4M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$28.43B
Last Q Revenue
$7.68B
P/E Ratio
37.6
P/S Ratio
0.9x
EPS (TTM)
$0.81
Dividend Yield
0.00%
Dilution (1yr)
+3.2%
MDLN logo

MEDLINE INC-CL A

MDLN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$28.4Bβ–² +11.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
26.4%β–² +7.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.2Bβ–Ό βˆ’0.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.3Bβ–Ό βˆ’7.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
812.0Mβ–² +3.2% YoY
StockOtter Β· stockotter.space

About MEDLINE INC-CL A

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100
Analyst data unavailable.

Latest News & Updates

GlobeNewsWireΒ·18h ago

$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dr

GlobeNewsWireΒ·1d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (β€œMedline” or the β€œCompany”) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton

GlobeNewsWireΒ·2d ago

$MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro

GlobeNewsWireΒ·5d ago

MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro

GlobeNewsWireΒ·7d ago

MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ  Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dr

GlobeNewsWireΒ·9d ago

MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro